Identification of HAGHL as a novel metabolic oncogene regulating human colorectal cancer progression
- PMID: 36417085
- DOI: 10.1007/s12094-022-03008-1
Identification of HAGHL as a novel metabolic oncogene regulating human colorectal cancer progression
Abstract
Purpose: Cancer development remains the most challenging obstacle in colorectal cancer (CRC) treatment. The current study aims to identify and demonstrate novel oncogenes for CRC.
Methods: The CRC data of the Cancer Genome Atlas database and the Gene Expression Omnibus database were subjected to bioinformatics analysis to identify the novel potential diagnostic and prognostic biomarkers for CRC. Immunohistochemical assay, western blot, and quantitative PCR (qPCR) were used to analyze hydroxyacylglutathione hydrolase-like (HAGHL) gene expression in CRC tissues and cultured CRC cells. D-Lactate colorimetric assay was applied to determine concentration of D-lactate in supernatants from CRC tissues and cell culture medium. Cell counting kit-8 (CCK-8) assay, flow cytometry, tumor xenografts experiment, and TUNEL staining analysis were performed to evaluate the function of HAGHL in CRC.
Results: We comprehensively analyzed the CRC data of the Cancer Genome Atlas database and the Gene Expression Omnibus database, and identified several novel potential diagnostic and prognostic biomarkers for CRC, including HAGHL, DNTTIP1, DHX34, and AP1S3. The expression of HAGHL, the strongest oncogenic activity gene, is positively related to D-lactate levels in CRC tissues and negatively associated with patient prognosis. HAGHL downregulation suppressed the production of D-lactate and induced apoptosis, resulting in inhibition of cell proliferation in vitro. In vivo experiment showed that knockdown of HAGHL induced cell apoptosis and inhibited tumor growth.
Conclusion: These findings suggest that HAGHL acts as a novel metabolic oncogene and demonstrate the underlying mechanism by which HAGHL regulates CRC progression, highlighting its utility as a diagnostic and prognostic factor and as a potential therapeutic target for the treatment of CRC.
Keywords: Colorectal cancer; D-Lactate; Glyoxalase system; HAGHL; Oncogene.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Similar articles
-
LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.Int J Med Sci. 2019 Jan 1;16(1):51-59. doi: 10.7150/ijms.27359. eCollection 2019. Int J Med Sci. 2019. PMID: 30662328 Free PMC article.
-
CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.J Exp Clin Cancer Res. 2020 Aug 15;39(1):160. doi: 10.1186/s13046-020-01642-7. J Exp Clin Cancer Res. 2020. PMID: 32799891 Free PMC article.
-
MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.Cancer Biomark. 2019;26(2):229-237. doi: 10.3233/CBM-190183. Cancer Biomark. 2019. PMID: 31524145
-
Knockdown of circAPLP2 Inhibits Progression of Colorectal Cancer by Regulating miR-485-5p/FOXK1 Axis.Cancer Biother Radiopharm. 2021 Nov;36(9):737-752. doi: 10.1089/cbr.2019.3310. Epub 2020 Apr 24. Cancer Biother Radiopharm. 2021. PMID: 32343603
-
Novel biomarkers for the diagnosis and prognosis of colorectal cancer.Intest Res. 2020 Apr;18(2):168-183. doi: 10.5217/ir.2019.00080. Epub 2019 Nov 30. Intest Res. 2020. PMID: 31766836 Free PMC article. Review.
Cited by
-
Comprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations.Int J Mol Sci. 2025 Jul 25;26(15):7208. doi: 10.3390/ijms26157208. Int J Mol Sci. 2025. PMID: 40806338 Free PMC article.
-
Intron retention as an excellent marker for diagnosing depression and for discovering new potential pathways for drug intervention.Front Psychiatry. 2024 Sep 19;15:1450708. doi: 10.3389/fpsyt.2024.1450708. eCollection 2024. Front Psychiatry. 2024. PMID: 39364384 Free PMC article.
-
Transcriptomic Profiles Associated with Experimental Placebo Effects in Chronic Pain.Clin Pharmacol Ther. 2024 Aug;116(2):380-389. doi: 10.1002/cpt.3286. Epub 2024 May 6. Clin Pharmacol Ther. 2024. PMID: 38711244 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases